One of the greatest challenges in tissue engineering has always been "vascularization"—getting blood to flow through a thick biological substitute to keep the cells alive. In early 2026, the industry has achieved a breakthrough with "pre-vascularized" scaffolds. These substitutes include "micro-fluidic" channels that are "pre-seeded" with endothelial cells (the cells that line blood...
Acellular dermal matrix (ADM) biological skin substitutes — the decellularized human, porcine, or bovine dermal tissue providing scaffold-based wound healing for diabetic foot ulcers, venous leg ulcers, and burns representing the fastest-growing segment in advanced wound care — creates the most clinically transformative market category, with the Biological Skin Substitutes Market...